Symbol="APLS"
AssetType="Common Stock"
Name="Apellis Pharmaceuticals Inc"
Description="Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1492422"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3739434000"
EBITDA="-639102016"
PERatio="None"
PEGRatio="None"
BookValue="3.547"
DividendPerShare="0"
DividendYield="0"
EPS="-5.9"
RevenuePerShareTTM="0.962"
ProfitMargin="0"
OperatingMarginTTM="-6.05"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-1.581"
RevenueTTM="105887000"
GrossProfitTTM="69786000"
DilutedEPSTTM="-5.9"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.118"
AnalystTargetPrice="92.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="51.26"
PriceToBookRatio="17.67"
EVToRevenue="42.79"
EVToEBITDA="-8.03"
Beta="1.268"
num_52WeekHigh="94.75"
num_52WeekLow="29.7"
num_50DayMovingAverage="78.8"
num_200DayMovingAverage="65.4"
SharesOutstanding="116457000"
DividendDate="None"
ExDividendDate="None"
symbol="APLS"
open="31.25"
high="34.66"
low="29.84"
price="32.11"
volume="9198137.00"
latest_trading_day="2023-07-27"
previous_close="31.95"
change="0.16"
change_percent="0.5008%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="9"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="91"
Volume_recent_avg="2485523"
Change_recent_avg="-0.06"
Delta_recent_avg="3.16"
Variance_recent_avg="1.58"
Change_ratio_recent_avg="-0.47"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="91"
Aroon_momentum_negative="9"
image_negative_thumbnail_id_1="94"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_negative_thumbnail_id_2="1120"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0153.jpeg"
image_neutral_thumbnail_id_1="524"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="1003"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0165.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
